EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance

Manouk Dam iD, Laura M M de Haan, Tiny Hoekstra, Marc Vervloet, Frans J van Ittersum, Peter J M Weijs, Brigit C van Jaarsveld

Hemodialysis International · 2025

DOI: 10.1111/hdi.13265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hemodialysis International, 2025. Verfasst von Manouk Dam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VU University Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Renal Dialysis, Natriuretic Peptide, Brain, Cardiovascular Diseases, Physical Functional Performance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baxter International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The cardiovascular biomarkers troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 are elevated in hemodialysis patients and associated with an increased cardiovascular mortality risk. Nocturnal hemodialysis improves the fluid status in hemodialysis patients. Therefore, we investigated whether nocturnal hemodialysis (7–8 h sessions) was associated with lower levels of troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 in comparison to conventional hemodialysis. Second, we investigated whether these biomarkers were independently associated with physical performance in hemodialysis patients.

Methods

A prospective cohort of 33 hemodialysis patients was compared to 32 patients who voluntarily switched from conventional hemodialysis to nocturnal hemodialysis. First, we studied the difference between the two cohorts in change over 12 months of troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 with linear mixed models. Second, the associations between these biomarkers and physical‐activity monitor, six minute walk test, and physical component summary score were assessed at baseline, 6 and 12 months.

Findings

N‐terminal pro‐B‐type natriuretic peptide increased 122% during conventional hemodialysis, whereas it decreased 31% during nocturnal hemodialysis ( p = 0.001). In conventional hemodialysis, fibroblast growth factor 23 rose numerically by 19% (23%–66%) in 12 months, while a decline of 44% (21%–58%) was found in nocturnal hemodialysis patients ( p = 0.17). Troponin T did not differ between groups. Regarding physical performance, a higher N‐terminal pro‐B‐type natriuretic peptide (per 1000 ng/L) and fibroblast growth factor 23 (per 1000 RU/mL) were associated with lower physical component summary scores of −0.02 ( p = 0.02) and −0.04 ( p = 0.05), respectively. Troponin T was not associated with physical performance.

Discussion

Our findings showed that nocturnal hemodialysis was associated with a decrease in N‐terminal pro‐B‐type natriuretic peptide. This suggested that nocturnal hemodialysis diminished volume overload and thereby myocardial stretch. Additionally, lower levels of N‐terminal pro‐B‐type natriuretic peptide and fibroblast growth factor 23 were found to be associated with better self‐reported physical performance scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisNatriuretic Peptide, BrainCardiovascular DiseasesPhysical Functional PerformanceHumansMaleFemaleBiomarkersMiddle AgedProspective StudiesAgedTroponin TFibroblast Growth Factor-23Peptide Fragments

Stichwörter der Autor:innen

cardiovascular biomarkersnocturnal hemodialysisphysical performance

Substanzen

BiomarkersTroponin TNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Fibroblast Growth Factor-23Peptide Fragments

Autor:innen und Institutionen

  • Department of Nutrition and Dietetics, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VU University Amsterdam, Amsterdam, the Netherlands.
  • Department of Nephrology, Amsterdam UMC, VU University Amsterdam, Amsterdam, the Netherlands.
  • Department of Nephrology, Radboud UMC, Nijmegen, the Netherlands.
  • Amsterdam University of Applied Sciences, Faculty of Sports and Nutrition, Department of Nutrition and Dietetics, the Netherlands.
  • Nephrocare Diapriva Dialysis Center, Amsterdam, the Netherlands.

ORCID-Profile: Manouk Dam

Förderung

  • Baxter International

Zitieren

APA

Dam, M., de Haan, L. M. M., Hoekstra, T., Vervloet, M., van Ittersum, F. J., Weijs, P. J. M., & van Jaarsveld, B. C. (2025). Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance. Hemodialysis International. https://doi.org/10.1111/hdi.13265

Vancouver

Dam M, de Haan LMM, Hoekstra T, Vervloet M, van Ittersum FJ, Weijs PJM, et al. Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance. Hemodialysis International. 2025. doi:10.1111/hdi.13265

BibTeX
@article{Dam2025,
  author = {Dam, Manouk and de Haan, Laura M M and Hoekstra, Tiny and Vervloet, Marc and van Ittersum, Frans J and Weijs, Peter J M and van Jaarsveld, Brigit C},
  title = {Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance},
  journal = {Hemodialysis International},
  year = {2025},
  doi = {10.1111/hdi.13265}
}
Kostenlos starten →